PPARA collaborates with a considerable number of genetic markers and impacts the prognosis and TFS of CLL through several essential pathways, such as the regulation of cell adhesion, inflammation, reactive oxygen species, and cell differentiation. This evidence concerns the gene PPARA and B-cell chronic lymphocytic leukemia.